{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:39:24Z","timestamp":1755225564525,"version":"3.43.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neurot.2025.e00697","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:01:07Z","timestamp":1752609667000},"page":"e00697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Edition: Therapeutic advances in multiple sclerosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Patricia K.","family":"Coyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurot.2025.e00697_bib1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.27034","article-title":"Smouldering-associated worsening in multiple sclerosis: an international consensus statement on definition, biology, clinical implications, and future directions","volume":"96","author":"Scalfari","year":"2024","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2025.e00697_bib2","article-title":"The epidemiology, pathology and pathogenesis of MS: therapeutic implications","volume":"4","author":"Goodin","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib3","article-title":"Choosing initial MS therapy: personal, disease, and medication factors","volume":"4","author":"Cohen","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib4","article-title":"Impact of sex on MS therapy","volume":"4","author":"Coyle","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib5","article-title":"Pediatric multiple sclerosis: improving outcome through high-efficacy therapies","volume":"4","author":"Yeh","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib6","article-title":"C16 - revised McDonald criteria (2024): diagnosis and misdiagnosis of MS in 2024 and beyond","author":"Miller","year":"2025","journal-title":"AAN"},{"key":"10.1016\/j.neurot.2025.e00697_bib7","article-title":"Impact of age: when to change, when to stop therapy","volume":"4","author":"Siddique","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib8","article-title":"Role of soluble biomarkers in treating multiple sclerosis and neuroinflammatory conditions","volume":"4","author":"Bose","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib9","article-title":"Progressive multiple sclerosis: evaluating current therapies and exploring future treatment strategies","volume":"4","author":"Martinez","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib10","article-title":"Beyond relapses: how BTK inhibitors are shaping the future of progressive MS treatment","volume":"4","author":"Naydovich","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib11","article-title":"Therapeutic advances in multiple sclerosis: novel therapies (immune checkpoint inhibitors, CAR-T, anti-CD40L)","volume":"4","author":"Conway","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00697_bib12","article-title":"Repair mechanisms of the central nervous system: from axon sprouting to remyelination","volume":"4","author":"Kaunzner","year":"2025","journal-title":"Neurotherapeutics"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925001758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:04:56Z","timestamp":1755090296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925001758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878747925001758"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00697","relation":{},"ISSN":["1878-7479"],"issn-type":[{"type":"print","value":"1878-7479"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Special Edition: Therapeutic advances in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00697"}}